ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences
PRINCETON, N.J., Sept. 16, 2024 ( GLOBE NEWSWIRE ) -- ANI Pharmaceuticals, Inc. ( "ANI" or "the Company" ) ( Nasdaq: ANIP ) today announced the completion of its previously announced acquisition of Alimera Sciences, Inc. ( Nasdaq: ALIM ) ( "Alimera" ) .
| Ticker |
Sentiment |
Impact |
|
PWP
|
Neutral
|
2 %
|
|
ALIM
|
Neutral
|
7 %
|
|
ANIP
|
Somewhat Bullish
|
7 %
|
